Lam Research (LRCX) Tops Q4 EPS by 13c, Beats on Revenue; Offers Q1 Guidance
Get Alerts LRCX Hot Sheet
Price: $353.17 --0%
EPS Growth %: +26.3%
Financial Fact:
Diluted net income (loss) per share: 1.47
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: +26.3%
Financial Fact:
Diluted net income (loss) per share: 1.47
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Lam Research (NASDAQ: LRCX) reported Q4 EPS of $1.33, $0.13 better than the analyst estimate of $1.20. Revenue for the quarter came in at $5.17 billion versus the consensus estimate of $4.99 billion.
GUIDANCE:
Lam Research sees Q1 2026 EPS of $1.10-$1.30, versus the consensus of $1.00. Lam Research sees Q1 2026 revenue of $4.9-5.5 billion, versus the consensus of $4.66 billion.
For earnings history and earnings-related data on Lam Research (LRCX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lam Research (LRCX) PT Raised to $400 at Mizuho
- Ionis Pharmaceuticals (IONS) reaffirms guidance
- Pelagos Insurance Capital (PLGO) PT Raised to $28 at Citizens on Rising Book Value
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share